Generate Biomedicines, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $6,314 | $7,224 | $10,130 | $8,818 |
Gross Profit | 6,314 | 3,951 | ||
EBITDA | -63,823 | -60,838 | ||
EBIT | -67,047 | -64,111 | ||
Net Income | -67,255 | -61,446 | -52,429 | -41,685 |
Net Change In Cash | 6,314 | 7,224 | 10,130 | 8,818 |
Free Cash Flow | -58,877 | -84,169 | -48,907 | -53,927 |
Cash | 135,359 | 160,575 | ||
Basic Shares | 128,240 | 128,192 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $31,893 | $20,459 |
Gross Profit | 31,893 | 20,459 |
EBITDA | -208,488 | -163,705 |
EBIT | -221,666 | -179,054 |
Net Income | -203,154 | -173,771 |
Net Change In Cash | 31,893 | 20,459 |
Free Cash Flow | -204,133 | -121,197 |
Cash | 121,650 | 176,269 |
Basic Shares | 50,088 | 127,450 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.52 |
2026-03-31 | -$1.07 |